Sumit Kumar, Rashmi Arora, Shalini Gupta, Nancy Ahuja, Ella Bhagyaraj, Ravikanth Nanduri, Rashi Kalra, Asheesh Kumar Khare, Saumyata Kumawat, Vipashu Kaushal, Mahathi Sharma, Pawan Gupta
The regulation of RBC homeostasis by erythropoietin (EPO) is critical for O2 transport and maintaining the adequate number of RBCs in vertebrates. Therefore, dysregulation in EPO synthesis results in disease conditions like polycythemia in the case of excessive EPO production and anemia, which occurs when EPO is inadequately produced. EPO plays a crucial role in treating anemic patients; however, its overproduction can increase blood viscosity, potentially leading to fatal heart failure. Consequently, the identification of druggable transcription factors (TFs) and their associated ligands capable of regulating EPO offers a promising therapeutic approach to address EPO-related disorders...
May 15, 2024: Blood Advances